Related Experiment Videos
Interleukin 10 treatment for rheumatoid arthritis
1Room 34229, Duke South Hospital, Box 3874, Duke University Medical Center, Erwin Road, Durham, NC 27710, USA.
Annals of the Rheumatic Diseases
|December 1, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.
Clinical and experimental immunology·2017
Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
Arthritis & rheumatology (Hoboken, N.J.)·2015
Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.
Arthritis & rheumatology (Hoboken, N.J.)·2014
Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis.
Clinical and experimental rheumatology·2009
Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases.
Annals of the rheumatic diseases·2026
Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.
Annals of the rheumatic diseases·2026
Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis.
Annals of the rheumatic diseases·2026
Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseases.
Annals of the rheumatic diseases·2026